Saturday Jun 21, 2025
NEWSLETTER
www.israelhayom.com
  • Home
  • Iran War
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
  • Home
  • Iran War
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
  • In Memoriam
www.israelhayom.com
Home In Brief

UK approves AstraZeneca vaccine

by  AP and ILH Staff
Published on  12-30-2020 12:50
Last modified: 04-08-2021 08:04
UK approves AstraZeneca vaccineJohn Cairns/University of Oxford via AP

A vial of the coronavirus vaccine developed by AstraZeneca and Oxford University | Photo: John Cairns/University of Oxford via AP

Share on FacebookShare on Twitter

Britain on Wednesday became the first country to authorize an easy-to-handle COVID-19 vaccine whose developers hope it will become the "vaccine for the world." The approval and a shift in policy that will speed up rollout of the vaccine in the UK comes as a surge in infections threatens to swamp British hospitals.

The Department of Health said it had accepted a recommendation from the Medicines and Healthcare Products Regulatory Agency to authorize emergency use of the vaccine developed by Oxford University and UK-based drugmaker AstraZeneca.

Follow Israel Hayom on Facebook and Twitter

"The rollout will start on Jan. 4 and will really accelerate into the first few weeks of next year," British Health Secretary Matt Hancock told told Sky News. Britain has bought 100 million doses of the vaccine.

Hundreds of thousands of people in the UK have already received a different vaccine, made by US drugmaker Pfizer and German firm BioNTech.

Related Posts

In first, police inaugurates bulletproof ambulances

In first, police inaugurates bulletproof ambulances

by Itsik Saban

"We have only recently finished debriefing the events of Oct. 7," Israel Police Commissioner Yaakov Shabtai says. "There were officers...

Israel to hold 7th annual national waste conferenceHiriya Recycling Park

Israel to hold 7th annual national waste conference

by ILH Staff

  The 7th Annual Waste Management Conference, set for Tuesday, comes as Israel faces a critical juncture in waste management....

Rare archival photos unveiled in honor of Jerusalem DayLazer Doner, KKL-JNF Archive

Rare archival photos unveiled in honor of Jerusalem Day

by ILH Staff

  In celebration of Jerusalem Day, Keren Kayemeth LeIsrael-Jewish National Fund has unveiled rare archival photos, offering a glimpse into...

Menu

Analysis 

Archaeology

Blogpost

Business & Finance

Culture

Exclusive

Explainer

Environment

 

Features

Health

In Brief

Jewish World

Judea and Samaria

Lifestyle

Cyber & Internet

Sports

 

Diplomacy 

Iran & The Gulf

Gaza Strip

Politics

Shopping

Terms of use

Privacy Policy

Submissions

Contact Us

About Us

The first issue of Israel Hayom appeared on July 30, 2007. Israel Hayom was founded on the belief that the Israeli public deserves better, more balanced and more accurate journalism. Journalism that speaks, not shouts. Journalism of a different kind. And free of charge.

All rights reserved to Israel Hayom

Hosted by sPD.co.il

  • Home
  • Iran War
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il

Newsletter

[contact-form-7 id=”508379″ html_id=”isrh_form_Newsletter_en” title=”newsletter_subscribe”]

  • Home
  • Iran War
  • News
    • Gaza War
    • US Election Coverage
    • Middle East
    • Cyber & Internet
    • Business & Finance
    • Sports
  • Opinions
  • Jewish World
    • Archaeology
    • Antisemitism
  • Lifestyle
    • Food
    • Travel
    • Fashion
    • Culture
  • Magazine
    • Feature
    • Analysis
    • Explainer
    • Environment & Wildlife
    • Health & Wellness
  • In Memoriam
  • Subscribe to Newsletter
  • Submit your opinion
  • Terms and conditions

All rights reserved to Israel Hayom

Hosted by sPD.co.il